[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @bio_report BioReport BioReport posts on X about $lmt, $gral, $srpt, people with the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::2933996796/interactions)  - X Week XXXXXX +78,487% - X Month XXXXXX +391% - X Months XXXXXXX -XX% - X Year XXXXXXX +357% ### Mentions: X [#](/creator/twitter::2933996796/posts_active)  - X Months XXX -XX% - X Year XXX +314% ### Followers: XXXXX [#](/creator/twitter::2933996796/followers)  - X Week XXXXX +0.94% - X Month XXXXX -XXXX% - X Months XXXXX +15% - X Year XXXXX +74% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::2933996796/influencer_rank)  ### Social Influence [#](/creator/twitter::2933996796/influence) --- **Social category influence** [stocks](/list/stocks) XXXXX% [cryptocurrencies](/list/cryptocurrencies) XXXXX% **Social topic influence** [$lmt](/topic/$lmt) #33, [$gral](/topic/$gral) #268, [$srpt](/topic/$srpt) 4.76%, [people with](/topic/people-with) 4.76%, [$165m](/topic/$165m) XXXX% **Top accounts mentioned or mentioned by** [@connorsullychi](/creator/undefined) [@hasurfer297](/creator/undefined) [@repmikecollins](/creator/undefined) [@radicalwhig1642](/creator/undefined) [@runeweb3](/creator/undefined) [@acyn](/creator/undefined) [@randpaul](/creator/undefined) [@jdvance](/creator/undefined) [@secscottbessent](/creator/undefined) [@realdonaldtrump](/creator/undefined) [@squawksquare](/creator/undefined) [@aimrue](/creator/undefined) [@stocktavia](/creator/undefined) [@a_i_m_rue](/creator/undefined) **Top assets mentioned** [Limitus (LMT)](/topic/$lmt) [GRAIL, Inc. Common Stock (GRAL)](/topic/$gral) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) ### Top Social Posts [#](/creator/twitter::2933996796/posts) --- Top posts by engagements in the last XX hours "$SRPT continues to release really good data in DMD" [X Link](https://x.com/bio_report/status/1979583629715247152) [@bio_report](/creator/x/bio_report) 2025-10-18T16:21Z 1181 followers, 4960 engagements "$LMT extremely bizarre reaction to a triple beat and guidance raise. Would expect rebound quickly" [X Link](https://x.com/bio_report/status/1980718075369648589) [@bio_report](/creator/x/bio_report) 2025-10-21T19:29Z 1181 followers, XXX engagements "$GRAL data looks heavily massaged and hard to compare to previous data sets. Now calling it episodic sensitivity and introducing PET imaging confirmation which will kill test adoption if ever gets approved. Assuming Stage X sensitivity which is the most important still bad" [X Link](https://x.com/bio_report/status/1979583377851510981) [@bio_report](/creator/x/bio_report) 2025-10-18T16:20Z 1181 followers, XXX engagements "$GRAL the harm of healthy cancer sceeening should be the focus. Like how many people with negative test forego proper guideline screening. Theres a reason USPSTF doesnt recommend cheap prostate screening. Remove prostate from Galleri and results diluted dramatically" [X Link](https://x.com/bio_report/status/1979607210453086482) [@bio_report](/creator/x/bio_report) 2025-10-18T17:55Z 1181 followers, 2624 engagements "$GRAL Excluded PSA cancers: 17/131 = XX% Excluded recurrences: 19/131 = XXXX% Remaining early-stage: 61/23161 = XXXX% And so the true incremental gain over standard screening is. XX cancers / 23161 people = XXXX% = yes cost per each incremental cancer is $1.65M" [X Link](https://x.com/bio_report/status/1979696655227371637) [@bio_report](/creator/x/bio_report) 2025-10-18T23:50Z 1181 followers, 2411 engagements "$LMT beats and raises on both revenue and profit and stock down. Makes no sense. Has XXX years of backlog now" [X Link](https://x.com/bio_report/status/1980661958119694556) [@bio_report](/creator/x/bio_report) 2025-10-21T15:46Z 1181 followers, XXX engagements "$LMT looking juicy now. Going in for another bite after that earnings and illogical stock reaction" [X Link](https://x.com/bio_report/status/1981031273574305807) [@bio_report](/creator/x/bio_report) 2025-10-22T16:13Z 1181 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@bio_report BioReport
BioReport posts on X about $lmt, $gral, $srpt, people with the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXXX +78,487%
- X Month XXXXXX +391%
- X Months XXXXXXX -XX%
- X Year XXXXXXX +357%
Mentions: X #
- X Months XXX -XX%
- X Year XXX +314%
Followers: XXXXX #
- X Week XXXXX +0.94%
- X Month XXXXX -XXXX%
- X Months XXXXX +15%
- X Year XXXXX +74%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence stocks XXXXX% cryptocurrencies XXXXX%
Social topic influence $lmt #33, $gral #268, $srpt 4.76%, people with 4.76%, $165m XXXX%
Top accounts mentioned or mentioned by @connorsullychi @hasurfer297 @repmikecollins @radicalwhig1642 @runeweb3 @acyn @randpaul @jdvance @secscottbessent @realdonaldtrump @squawksquare @aimrue @stocktavia @a_i_m_rue
Top assets mentioned Limitus (LMT) GRAIL, Inc. Common Stock (GRAL) Sarepta Therapeutics, Inc. (SRPT)
Top Social Posts #
Top posts by engagements in the last XX hours
"$SRPT continues to release really good data in DMD"
X Link @bio_report 2025-10-18T16:21Z 1181 followers, 4960 engagements
"$LMT extremely bizarre reaction to a triple beat and guidance raise. Would expect rebound quickly"
X Link @bio_report 2025-10-21T19:29Z 1181 followers, XXX engagements
"$GRAL data looks heavily massaged and hard to compare to previous data sets. Now calling it episodic sensitivity and introducing PET imaging confirmation which will kill test adoption if ever gets approved. Assuming Stage X sensitivity which is the most important still bad"
X Link @bio_report 2025-10-18T16:20Z 1181 followers, XXX engagements
"$GRAL the harm of healthy cancer sceeening should be the focus. Like how many people with negative test forego proper guideline screening. Theres a reason USPSTF doesnt recommend cheap prostate screening. Remove prostate from Galleri and results diluted dramatically"
X Link @bio_report 2025-10-18T17:55Z 1181 followers, 2624 engagements
"$GRAL Excluded PSA cancers: 17/131 = XX% Excluded recurrences: 19/131 = XXXX% Remaining early-stage: 61/23161 = XXXX% And so the true incremental gain over standard screening is. XX cancers / 23161 people = XXXX% = yes cost per each incremental cancer is $1.65M"
X Link @bio_report 2025-10-18T23:50Z 1181 followers, 2411 engagements
"$LMT beats and raises on both revenue and profit and stock down. Makes no sense. Has XXX years of backlog now"
X Link @bio_report 2025-10-21T15:46Z 1181 followers, XXX engagements
"$LMT looking juicy now. Going in for another bite after that earnings and illogical stock reaction"
X Link @bio_report 2025-10-22T16:13Z 1181 followers, XXX engagements